All posts by: Michael Zand

About Michael Zand

Stem Cell Injections Rejuvenate Aging Rat Hearts – Genetic Engineering & Biotechnology News (press release)

Continue reading

2017-08-14 NEWS

Genetic Engineering & Biotechnology News (press release)

Stem Cell Injections Rejuvenate Aging Rat Hearts
Genetic Engineering & Biotechnology News (press release)
Researchers at the Cedars-Sinai Heart Institute have shown that injecting cardiac stem cells from young rats into the hearts of old rats can help to reverse the natural cardiac aging process. Results from the studies, led by Eduardo Marbán, M.D., Ph.D
Could this ‘CURE’ heart ageing? Scientists rejuvenate old hearts by injecting younger stem cells in world-first Daily Mail
Specialized stem cells may rejuvenate aged heartsMedical News Today
Cardiac stem cells from young hearts could rejuvenate old hearts, new study showsEurekAlert (press release)

all 5 news articles »

Continue reading

2017-08-14 NEWS

CNN

‘Unexpected fountain of youth’ found in cardiac stem cells, says researcher
CNN
(CNN) Cardiac stem cells derived from young hearts helped reverse the signs of aging when directly injected into the old hearts of elderly rats, a study published Monday in the European Heart Journal demonstrated. The old rats appeared newly
Stem Cell Injections Rejuvenate Aging Rat HeartsGenetic Engineering & Biotechnology News (press release)
Specialized stem cells may rejuvenate aged heartsMedical News Today
Cardiac stem cells from young hearts could rejuvenate old heartsScience Daily
Daily Mail
all 5 news articles »
Continue reading

2017-08-14 NEWS

Phase 1 Trial Recruitment Complete for Atara’s ATA188 T-cell Immunotherapy for Progressive MS
Multiple Sclerosis News Today
Atara Biotherapeutics recently published an update of the company’s quarterly financial results and operational highlights, including the advancement of its T-cell based immunotherapy strategies for multiple sclerosis (MS) and cancer. One of the …

Continue reading

2017-08-14 NEWS

Genetic Literacy Project

CRISPR and the Ethics of Human Embryo Research
Foreign Affairs
News that U.S. scientists led by Oregon Health and Sciences University biologist Shoukrat Mitalipov have used the gene-editing technique known as CRISPR to modify the DNA of human embryos has led to renewed debate over human genetic engineering.
Viewpoint: Don’t expect the first CRISPR baby to be born in the USGenetic Literacy Project

all 2 news articles »

Continue reading

2017-08-14 NEWS

International Stem Cell Corporation Announces Operating Results for the Three and Six-Months ended June 30, 2017
GlobeNewswire (press release)
CARLSBAD, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem …

and more »

Continue reading

2017-08-14 NEWS

International Stem Cell Corporation Announces Operating Results for the Three and Six-Months ended June 30, 2017
Nasdaq
14, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and …

and more »